Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2020-2026
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
Market Analysis and Insights: Global Latent Tuberculosis Infection (LTBI) Testing Market
In 2019, the global Latent Tuberculosis Infection (LTBI) Testing market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Latent Tuberculosis Infection (LTBI) Testing Scope and Market Size
Latent Tuberculosis Infection (LTBI) Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Latent Tuberculosis Infection (LTBI) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Latent Tuberculosis Infection (LTBI) Testing market is segmented into Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Others, etc.
Segment by Application, the Latent Tuberculosis Infection (LTBI) Testing market is segmented into Household Contacts with Pulmonary TB, PLHIV, Others, etc.
Regional and Country-level Analysis
The Latent Tuberculosis Infection (LTBI) Testing market is analysed and market size information is provided by regions (countries).
The key regions covered in the Latent Tuberculosis Infection (LTBI) Testing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Latent Tuberculosis Infection (LTBI) Testing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Latent Tuberculosis Infection (LTBI) Testing business, the date to enter into the Latent Tuberculosis Infection (LTBI) Testing market, Latent Tuberculosis Infection (LTBI) Testing product introduction, recent developments, etc.
The major vendors include Qiagen, BioMerieux, Thermo Fisher Scientific, Danaher, Roche, Becton Dickinson, Agilent Technologies, Bio-Rad Laboratories, Eppendorf, Abbott Laboratories, etc.
This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Household Contacts with Pulmonary TB
PLHIV
Others
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Market Analysis and Insights: Global Latent Tuberculosis Infection (LTBI) Testing Market
In 2019, the global Latent Tuberculosis Infection (LTBI) Testing market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Latent Tuberculosis Infection (LTBI) Testing Scope and Market Size
Latent Tuberculosis Infection (LTBI) Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Latent Tuberculosis Infection (LTBI) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Latent Tuberculosis Infection (LTBI) Testing market is segmented into Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Others, etc.
Segment by Application, the Latent Tuberculosis Infection (LTBI) Testing market is segmented into Household Contacts with Pulmonary TB, PLHIV, Others, etc.
Regional and Country-level Analysis
The Latent Tuberculosis Infection (LTBI) Testing market is analysed and market size information is provided by regions (countries).
The key regions covered in the Latent Tuberculosis Infection (LTBI) Testing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Latent Tuberculosis Infection (LTBI) Testing Market Share AnalysisLatent Tuberculosis Infection (LTBI) Testing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Latent Tuberculosis Infection (LTBI) Testing business, the date to enter into the Latent Tuberculosis Infection (LTBI) Testing market, Latent Tuberculosis Infection (LTBI) Testing product introduction, recent developments, etc.
The major vendors include Qiagen, BioMerieux, Thermo Fisher Scientific, Danaher, Roche, Becton Dickinson, Agilent Technologies, Bio-Rad Laboratories, Eppendorf, Abbott Laboratories, etc.
This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories
Market segment by Type, the product can be split into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application, split into
Household Contacts with Pulmonary TB
PLHIV
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
